ARTICLE | Company News
Sosei, Mundipharma AD 923 deal
June 28, 2006 12:57 AM UTC
Sosei (Tokyo:4565) partnered with Mundipharma ( Cambridge, U.K.) to develop and commercialize Sosei's AD 923 for breakthrough cancer pain in Europe and other international markets, excluding North Ame...